


To produce high income, increasing at least in line with inflation, from a managed portfolio chiefly invested in UK equities and fixed interest stocks, although with some overseas exposure.
| Name | % Net Assets | 
|---|---|
| BP | 8.2% | 
| BP | 7.7% | 
| Royal Dutch Shell | 7.7% | 
| Astrazeneca | 5.9% | 
| GlaxoSmithKline | 5.0% | 
| Diageo | 3.7% | 
| Admiral Group | 3.5% | 
| ICAP | 3.0% | 
| Telefónica | 2.9% | 
| BG | 2.8% | 
| Key | % Net Assets | 
|---|---|
| 8.2% | |
| 7.7% | |
| 7.7% | |
| 5.9% | |
| 70.5% | 
| Date | 20-Aug-2025 | 
|---|---|
| NAV | 605.71p | 
| Currency | GBP | 
| Change | -0.33p | 
| % | -0.05% | 
| YTD change | 73.32p | 
| YTD % | 13.77% | 
| Fund Inception | 03/08/1987 | 
|---|---|
| Fund Manager | n/a | 
| TER | 1.83 (31-Oct-2013) | 
| Minimum Investment | |
|---|---|
| Initial | £500 | 
| Additional | n/a | 
| Savings | £100 | 
| Charges | |
|---|---|
| Initial | 5.00% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.02 | 
| Sharpe ratio | 0.11 | 
You are here: research